Yüklüyor......
CAR T-cell Therapy for Pancreatic Cancer
Chimeric antigen receptor (CAR) T-cell therapy utilizes genetic engineering to redirect a patient’s own T cells to target cancer cells. The remarkable results in hematological malignancies prompted investigating this approach in solid tumors such as pancreatic cancer. The complex tumor microenvironm...
Kaydedildi:
Yayımlandı: | J Surg Oncol |
---|---|
Asıl Yazarlar: | , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
2017
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5491361/ https://ncbi.nlm.nih.gov/pubmed/28346697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.24627 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|